| |
 |
 |
NeoDiagnostix develops novel molecular diagnostic
and prognostic tests for the treatment of cancer. Our test results eliminate the
ambiguity experienced in millions of samples analyzed by traditional
cytomorphology-based cell analyses. The company is committed to providing
physicians with information that will improve patient care and treatment.
|
|
|
|
